Redbud Medicine
Maggie Yin is an experienced professional in clinical operations and project management, currently serving as Vice President of Global Clinical Operations at D2V Clinical since July 2022. In this role, Maggie oversees a global project management team across China and the USA, managing various project directors, managers, and clinical operation leads. Previously, at HopeMed Medicine Inc., Maggie held the position of VP, Global Project Management and Clinical Operation, where responsibilities included oversight of CROs and building teams in multiple regions. Prior experience includes senior roles at Syneos Health and ICON plc, focusing on clinical development and later phase study operations throughout the Asia Pacific region. Maggie's career began at GE Healthcare, where significant contributions were made to the establishment of clinical research teams and compliance in China, followed by key positions at Bayer HealthCare, Johnson & Johnson, and NovoNordisk.
This person is not in any offices
Redbud Medicine
Redbud Medicine focuses on real-time data analysis during innovation and trials, provides innovative and efficient clinical development services for biotechnology companies in China and around the world, helps local Chinese biotechnology companies bring their products to the global market, and helps foreign biotechnology companies. Technologycompanies bring their products to China.